ArticleBone marrow transplantation2017

Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysis.

C Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.